S24-4 Perspective of Benefit Risk Evaluation in Post-Marketing
Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.42.101
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2011
Authors
Publisher
Japanese Society of Clinical Pharmacology and Therapeutics